Form D · Other Health Care
Avisa Pharma Inc.
Santa Fe, NM · CIK 0001516068
Offering snapshot reported May 3, 2021 · SEC filing
- Reported sold
- $693K Offering amount: $693K
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 16, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 3, 2021 | Initial | $693,336 | No comparison | 21 | SEC filing |
| Dec 21, 2020 | Initial | $495,000 | No comparison | 30 | SEC filing |
| Dec 21, 2020 | Initial | $200,000 | No comparison | 6 | SEC filing |
| Sep 22, 2020 | Initial | $734,177 | No comparison | 23 | SEC filing |
| Mar 30, 2020 | Amendment | $1,100,000 | $765,000vs May 31, 2019 | 12 | SEC filing |
| May 31, 2019 | Initial | $335,000 | No comparison | 5 | SEC filing |
| Jun 28, 2018 | Amendment | $3,573,729 | $129,000vs Jan 4, 2018 | 51 | SEC filing |
| Jan 4, 2018 | Amendment | $3,444,729 | $2,530,370vs Apr 21, 2016 | 48 | SEC filing |
| Apr 21, 2016 | Initial | $914,359 | No comparison | 17 | SEC filing |
| Oct 28, 2014 | Initial | $3,670,716 | No comparison | 23 | SEC filing |
| Apr 5, 2013 | Initial | $3,250,000 | No comparison | 17 | SEC filing |
| Mar 22, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398010
Source: Form D, filed May 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allan Bedwick | Director |
| Brian P. Birk | Director |
| Matthew R. Culler | Executive |
| Matt Culler | Director |
| David S. Joseph | Director, Executive |
| David Karshmer | Executive |
| Carol C. La Rotonda | Executive |
| John Maynard | Executive |
| William A. Miller | Director |
| J. Chuck Morrison | Director |
| Chuck J. Morrison | Director |
| Tom Morse | Director |
| Thomas R. Morse | Director |
| Elizabeth A. Perkett | Executive |
| Stuart Schoenman | Director |
| Stuart Schoenmann | Director |
| Graham S. Timmins | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1660 A Old Pecos Trail
Santa Fe, NM, 87505
Santa Fe, NM, 87505